Insider · CIK 0001380918

Kraws Jeffrey J

Reports to the SEC for 3 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001380918

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-05	TOVXTheriva Biologics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2025-04-29	TOVXTheriva Biologics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-12-14	TOVXTheriva Biologics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+110K sh	—	—	110,000
2022-12-15	TOVXTheriva Biologics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2021-12-23	TOVXTheriva Biologics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+200K sh	—	—	200,000
2020-12-30	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+150K sh	—	—	150,000
2020-11-20	VJETFlyte Aviation, Inc.A Award	Co-President	AAward	+200 sh	$5.43	+$1,086.3	5,533
2020-08-03	VJETFlyte Aviation, Inc.P Purchase	Co-President	PPurchase	+10K sh	$0.35	+$3,500	133,339
2020-08-03	VJETFlyte Aviation, Inc. · Warrants (right to buy)P Purchase	Co-President	PPurchase	+10K sh	—	—	10,000
2020-05-22	VJETFlyte Aviation, Inc.P Purchase	Co-President	PPurchase	+10K sh	$0.46	+$4,600	123,339
2019-12-20	VJETFlyte Aviation, Inc.F Tax Payment	Co-President	FTax Payment	−792 sh	$0.90	−$713.592	113,339
2019-12-04	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+250K sh	—	—	250,000
2019-12-04	VJETFlyte Aviation, Inc.F Tax Payment	Co-President	FTax Payment	−38.4K sh	$1.82	−$69.9K	114,131
2019-12-03	VJETFlyte Aviation, Inc. · Stock Option (Right to Buy)A Award	Co-President	AAward	+139K sh	—	—	139,052
2019-07-18	VJETFlyte Aviation, Inc.S Sale	Co-President	SSale	−11.9K sh	$2.93	−$35K	152,503
2019-06-13	VJETFlyte Aviation, Inc.S Sale	Co-President	SSale	−18K sh	$3.08	−$55.4K	164,433
2018-12-06	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+79.5K sh	—	—	79,500
2017-12-20	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+200K sh	—	—	200,000
2017-03-14	TOVXTheriva Biologics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+229K sh	$0.09	+$20.6K	228,773
2017-03-14	TOVXTheriva Biologics, Inc. · Stock Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−229K sh	—	—	0
2016-11-30	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+169K sh	—	—	168,750
2015-12-04	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+125K sh	—	—	125,000
2014-08-12	Saleen Automotive, Inc.Option to purchase common stockA Award	Director	AAward	+500K sh	—	—	500,000
2013-10-22	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+25K sh	—	—	412,105
2012-05-10	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+100K sh	—	—	387,105
2011-01-05	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+25K sh	—	—	287,105
2010-12-02	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+8,333 sh	—	—	262,105
2009-12-22	TOVXTheriva Biologics, Inc. · Option to purchase common stockA Award	Director	AAward	+8,333 sh	—	—	253,772
2007-11-02	TOVXTheriva Biologics, Inc. · Stock OptionsA Award	Director	AAward	+8,333 sh	—	—	237,106

Recent filings

Accepted (ET)
Jan 64
Kraws Jeffrey J0001104659-26-001383
SEC(opens sec.gov)
May 14
Kraws Jeffrey J0001104659-25-043507
SEC(opens sec.gov)
Dec 154
Kraws Jeffrey J0001104659-23-126371
SEC(opens sec.gov)
Dec 164
Kraws Jeffrey J0001104659-22-127975
SEC(opens sec.gov)
Dec 274
Kraws Jeffrey J0001104659-21-153627
SEC(opens sec.gov)
Dec 314
Kraws Jeffrey J0001104659-20-140991
SEC(opens sec.gov)
Nov 244
Kraws Jeffrey J0001209191-20-060220
SEC(opens sec.gov)
Aug 54
Kraws Jeffrey J0001209191-20-045195
SEC(opens sec.gov)
May 274
Kraws Jeffrey J0001209191-20-032338
SEC(opens sec.gov)
Dec 264
Kraws Jeffrey J0001209191-19-061922
SEC(opens sec.gov)
Dec 64
Kraws Jeffrey J0001104659-19-070375
SEC(opens sec.gov)
Dec 54
Kraws Jeffrey J0001209191-19-059371
SEC(opens sec.gov)
Jul 234
Kraws Jeffrey J0001209191-19-042949
SEC(opens sec.gov)
Jun 174
Kraws Jeffrey J0001209191-19-037452
SEC(opens sec.gov)
Dec 74
Kraws Jeffrey J0001144204-18-063630
SEC(opens sec.gov)
Dec 214
Kraws Jeffrey J0001144204-17-064828
SEC(opens sec.gov)
Mar 164
Synthetic Biologics, Inc.0001144204-17-015198
SEC(opens sec.gov)

Companies

Address

C/O THERIVA BIOLOGICS, INC., 9605 MEDICAL CENTER DRIVE, SUITE 270

ROCKVILLE, MD, 20850